Literature DB >> 2987484

Demonstration of an alpha adrenoceptor-mediated inotropic effect of norepinephrine in human atria.

T Skomedal, H Aass, J B Osnes, N B Fjeld, G Klingen, A Langslet, G Semb.   

Abstract

It has been claimed by other investigators that norepinephrine does not evoke a significant alpha adrenergic inotropic effect in human atria in contrast to epinephrine and phenylephrine, indicating a limitation of a possible functional role of the cardiac alpha adrenoceptors. We therefore characterized the inotropic effects of norepinephrine in isometrically contracting muscle strips from human atria obtained during open heart surgery. Both contraction and relaxation were studied by measuring developed tension and its first and second derivatives. Both the influence of propranolol and prazosin upon the inotropic responses to norepinephrine and the qualitative characteristics of the responses revealed that norepinephrine evoked both alpha and beta adrenergic inotropic effects. The alpha adrenergic response to norepinephrine was qualitatively different from the beta adrenergic effect and qualitatively similar to the alpha adrenergic effect of norepinephrine observed in other mammalian species. Although the alpha adrenergic effect was marked, the beta adrenergic effect was the dominating one as has also been found in other species. It is concluded that also in human atria norepinephrine evokes inotropic effects through both alpha and beta adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987484

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Electrophysiologic and inotropic effects of alpha-adrenoceptor stimulation in human isolated atrial heart muscle.

Authors:  U Jahnel; H Jakob; H Nawrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

2.  Alpha-adrenoceptor-mediated chronotropic response: influence of temperature and basal spontaneous rate.

Authors:  M C Camilion de Hurtado; O A Gende
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

3.  Adrenoceptor-mediated changes of action potential and force of contraction in human isolated ventricular heart muscle.

Authors:  H Jakob; H Nawrath; J Rupp
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

Review 4.  Selective updates on mechanisms of action of positive inotropic agents.

Authors:  G Grupp
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

Review 5.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

6.  Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.

Authors:  Jürgen F Heubach; Thomas Rau; Thomas Eschenhagen; Ursula Ravens; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

7.  Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?

Authors:  K L Williamson; K J Broadley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone-stimulated synthesis and identification as prostaglandylinositol cyclic phosphate.

Authors:  H K Wasner; U Salge; M Gebel
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

9.  Cardiac alpha- and beta-adrenoceptor sensitivity and binding characteristics after chronic reserpine pretreatment.

Authors:  R G Chess-Williams; P F Grassby; K J Broadley; D J Sheridan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

Review 10.  Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.

Authors:  Brian C Jensen; Timothy D OʼConnell; Paul C Simpson
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.